All trials will be conducted by the Consortium for Overgrowth Disorder Management and Evaluation of Therapeutics (COMET)
|Name of Trial||Trial Characteristics||Inclusion Criteria||Exclusion Criteria||Study Sites||Planned Start Date||Current Status|
|PIK3CA-Related Overgrowth Multinational Investigation of Sirolimus Efficacy (PROMISE)||UK|
|February 2016||Commenced in France/USA and UK|
If you wish to know more about the trial please contact us.